Dermapharm Holding SE buy thorstenm
Start price
12.01.23
/
80%
€39.44
Target price
12.01.26
€60.00
Performance (%)
-2.76%
End price
12.01.26
€38.35
Summary
This prediction ended on 12.01.26 with a price of €38.35. With a performance of -2.76%, the BUY prediction by thorstenm finished with a loss. thorstenm has 80% into this predictionDermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Dermapharm Holding SE | 4.762% | 4.762% | 22.888% | 7.177% |
| iShares Core DAX® | 4.244% | 2.864% | 14.030% | 49.549% |
| iShares Nasdaq 100 | 4.890% | 2.814% | 32.707% | 85.974% |
| iShares Nikkei 225® | 9.397% | 7.826% | 48.296% | 63.319% |
| iShares S&P 500 | 3.528% | 1.950% | 25.247% | 62.380% |
Comments by thorstenm for this prediction
In the thread Dermapharm Holding SE diskutieren
In the thread Trading Dermapharm Holding SE
Die von thorstenm gewählte maximale Laufzeit wurde überschritten